Changes of PVS ratios and volumes for different treatment periods and different dose levels (HD: high dose, SD: standard dose, and RD: reduced dose). by Ruitian Song (11045127)

Subjects:

Liver azoxystrobin residues after 1 and 2 months treatment with different doses of azoxystrobin on male rats. by Ekramy Halawa (11785086)

Liver acetamiprid residues after 1 and 2 months treatment of with different doses of acetamiprid on male rats. by Ekramy Halawa (11785086)

Pairwise comparison of adult longevity across treatments. P-values from pairwise comparisons between control conditions and irradiation doses. Values in boldface indicate significant differences (p < 0.05). by Flavia Cerasti (21655934)

“…P-values from pairwise comparisons between control conditions and irradiation doses. Values in boldface indicate significant differences (p < 0.05).…”

Forest plot of the effect of high-dose TXA on transfusion rate. by Xin Liu (43569)

Subjects:

Forest plot of the effect of high-dose TXA on operation time. by Xin Liu (43569)

Subjects:

Forest plot of the effect of high-dose TXA on intraoperative blood loss. by Xin Liu (43569)

Subjects:

Radiation can decrease the expression of the SCFAs in colon contents. by Liying Zhang (102453)

Subjects:

Treatment with ICs causes a significant decrease in podocyte proliferation. by George Haddad (470789)

Flow diagram of different experiments and the study process. by Omid Mehrpour (9385929)

Subjects:

The wound appearance of different groups during the period of study (a) and the percentage of wound reduction in treated groups on different days (b). by Omid Mehrpour (9385929)

Subjects:

Subgroup Meta Analysis for HE Incidence Based on Treatment Duration and Dose. by Yangyang Hu (3309009)

“…<p>RFX treatment was more effective in the treatment duration >1 month subgroup (RR = 0.55), but no statistically significant in the treatment duration ≤1 month subgroup(A); The difference in HE incidence between the RFX low-dose group (≤550 mg/d) and conventional dose group (1100 mg/d) was not statistically significant (RR = 0.80) <b>(B)</b>.…”

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. by Patricia Sikorski (1320966)

“…Samples were separated based on clinical outcome (X-axis, orange treatment responsive, teal treatment non-responsive). …”

Bias risk assessments for each RCT study. by Xin Liu (43569)

Subjects:

The flow chart of studies selecting. by Xin Liu (43569)

Subjects:

Characteristics of the included studies. by Xin Liu (43569)

Subjects:

Funnel plots for intraoperative blood loss. by Xin Liu (43569)

Subjects:

Bias risk assessments for each RCS study. by Xin Liu (43569)

Subjects:

Summary of results. by Xin Liu (43569)

Subjects: